Cell line · CVCL_1490
NCI-H1703
Cancer cell line, Homo sapiens. Lung squamous cell carcinoma. 50 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. NCI-H1703. Cell lines, record CVCL_1490. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1490
On this page
Cell line
As Cellosaurus gives it.
- Name
- NCI-H1703
- Accession
- CVCL_1490
- RRID
- RRID:CVCL_1490
- Synonyms
- H1703, H-1703, NCIH1703
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 54Y
- Category
- Cancer cell line
- Diseases
- Lung squamous cell carcinoma (NCIt C3493)
- Derived from
- Lung (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | Indicated to have a TP53 p.Glu285Lys (c.853G>A) mutation according to PubMed=1311061. |
Source Cellosaurus
Papers50
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Circulating Tumour Cell GALNT13 Expression Is Associated with Prognosis and Treatment Response in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non-Small Cell Lung Cancer. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting the CHD3 chromatin remodeler exploits a synthetic lethal vulnerability in dual SMARCA4/SMARCA2-deficient cancers via derepression of PARD3B. | NPJ Precis Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mitofusin-2 suppresses tumor immune escape through EGFR/STAT3-mediated PD-L1 transcription. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| C1RL-AS1/microRNA-424-5p/adrenoceptor β2 axis: A novel regulatory mechanism in lung adenocarcinoma associated with immune infiltration and prognosis. | PLoS One | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Macropinocytosis and Vascularization Determine Response to mTOR Inhibitors in Lung Squamous Cell Carcinoma. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Epsin3 promotes non-small cell lung cancer progression via modulating EGFR stability. | Cell Biosci | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer Models. | Mol Cancer Ther | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial Apoptosis. | Cancer Res Commun | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non-Small Cell Lung Cancer Patient-Derived Tumor Organoids. | Clin Cancer Res | 2024 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 50
See all 50 papersRelatives5
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE NCI-H1703-Cas9 | CVCL_F5QA | Cell lines | |
| Derived from it | EDITGENE NCI-H1703-FLUC | CVCL_F5TC | Cell lines | |
| Derived from it | H1703/LKB1shRNA | CVCL_E7UZ | Cell lines | |
| Derived from it | H1703/pLKO.1 | CVCL_E7V0 | Cell lines | |
| Derived from it | HyCyte NCI-H1703 KO-hGALNT14 | CVCL_F1S6 | Cell lines |
Cell banks5
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-5889 | ATCC | |
| AddexBio | C0016008/4676 | Cellosaurus | |
| CLS | 305090 | CLS | |
| EDITGENE | EDC00322 | EDITGENE | |
| KCLB | 91703 | KCLB |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1490
GET https://conductscience.org/api/cell-lines/v1/CVCL_1490/papers?page=2